Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon

Gut

Volumn 52, Issue 6, 2003, Pages 840-846

  Berrebi, D ^a   Maudinas, R ^a   Hugot, J P ^a   Chamaillard, M ^b   Chareyre, F ^b   De Lagausie, P ^a   Yang, C ^d   Desreumaux, P ^d   Giovannini, M ^a   Cezard J P ^a   Zouali, H ^c   Emilie, D ^c   Peuchmaur, M ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c INSERM   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADOLESCENT; ARTICLE; CARD15 GENE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOPLASM; FEMALE; GENE; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE EPITHELIUM CELL; MACROPHAGE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

ACUTE DISEASE; ADOLESCENT; APPENDICITIS; CARRIER PROTEINS; CHILD; COLON; CROHN DISEASE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; INTESTINAL MUCOSA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0038237665     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.6.840     Document Type: Article

References (31)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
2. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
3. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
4. Rioux JD, Daly MJ, Silverberg MS, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001;29:223-7.
5. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crahn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genetics 2001;10:445-56.
6. Kosiewicz MM, Nast CC, Krishnan A, et al. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest 2001;107:695-702.
7. Shanahan F. Seminar Crohn's disease. Lancet 2002;359:62-9.
8. Berrebi D, Besnard M, Fromont-Hankard G, et al. Interleukin-12 expression is focally enhanced in the gastric mucosa of pediatric patients with Crohn's disease. Am J Pathol 1998;152:667-72.
9. Parrello T, Monteleone G, Cucchiara S, et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J Immunol 2000;165:7234-9.
10. Pizzaro TT, Michie MH, Bentz M, et al IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999;162:6829-35.
11. Lindsay JO, Hodgson HJ. Review article: the immunoregulatory cytokine interleukin- 10 - a therapy for Crohn's disease? Aliment Pharmacol Ther 2001;15:1709-16.
12. Fiocchi C. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation. J Clin Invest 2001;108:523-6.
13. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
14. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem 2001;276:4812-18.
15. Inohara N, Ogurc Y, Chen FF, et al. Human Nod1 confers responsiveness to bacterial lipopolysaccaharides. J Biol Chem 2001;276:2551-4.
16. Chamaillard M, Philpott D, Girardin SE, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003;100:3455-60.
17. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor κB in inflammatory bowel disease. Gut 1998;42:477-84.
18. Lesage S, Zouali H, Cézard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
19. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
20. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
21. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease cohort study. Lancet 2002;359:1661-5.
22. Radlmayr M, Torok HP, Martin K, et al. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002;122:2091-92.
23. Toy LS, Yio XY, Lin A, et al. Defective expression of pg180, a novel CD8 ligand on intestinal epithelial cells in inflammatory bowel disease: J Clin Invest 1997;100:2062-71.
24. Foussat A, Bouchet-Delbos L, Berrebi D, et al. Deregulation of the expression of the fractalkine/fractalkin receptor complex in HIV-1-infected patients. Blood 2001;98:1678-86.
25. Roach DR, Bean AG, Demangel C, et al. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 2002;168:4620-7.
26. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001;29:19-20.
27. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of Toll-Like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010-17.
28. Philpott DJ, Yamaoka S, Israel A, et al. Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol 2000;165:903-14.
29. Zareie M, Singh PK, Irvine EJ, et al. Monocyte/macrophage activation by normal bacteria and bacterial products. Implications for altered epithelial function in Crohn's disease. Am J Pathol 2001;158:1101-9.
30. Kobayashi K, Inohara N, Hernandez LD, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptative immune system. Nature 2002;416:194-9.
31. Gutierrez O, Pipaon C, Inohara N, et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002;277:41701-5.